PB EN

1.白内障 正方.jpg  2.近视 豹纹 正方.jpg  3.糖尿视网变 正方.jpg  4.黄斑病变 正方.jpg  5.正常 老人 正方.jpg  6.正常 健康 正方.jpg


When a patient, with gauze uncovered and eyes open, first word blurt out : I see light again !

This is the most exciting moment in my life.                                                                                             

                                                                                                                     Social Activist    Jun Zheng


Since the 21st century, increasingly more attention has been paid to the health of eyes. The increasing incidence of eye diseases, such as cataract, myopia, diabetic retinopathy and maculopathy, has become a worldwide problem.


According to the latest research report of World Health Organization :


1.Cataract is the leading cause of blindness in the world. An estimated 35% of the blindness and 25% of the moderate and severe visual impairment worldwide result from the untreated cataracts in time.


2.Nowadays, about 1.4 billion people worldwide suffer from myopia. Among them, the proportion of myopia reaches 47% in China, which is the highest in the world, as in the United States (42%), Japan (46%) and Singapore (59%).

 

3.The prevalence of diabetic retinopathy is 40.3% and 86% in patients with type 2 and type 1 diabetes mellitus, respectively, and retinopathy that threatens vision accounts for 8% and 42%, respectively.

 

4.Age-related macular degeneration (AMD) blindness accounts for 8.7% of global blindness. There are approximately 30 million AMD patients worldwide, and about 500,000 people are blinded due to AMD annually.

 

Over the years, extensive efforts have been made by international medical organizations, social groups and medical professionals of ophthalmology. Its common purpose is to address the problem of people's eye diseases and to improve the medical conditions of various regions.

 

ISEELIGHT adheres to the same development goal as the above organizations. ISEELIGHT manufacture ophthalmic medical devices to achieve sight recovery in large population. ISEELIGHT is committed to research and development in order to further improve the medical level.